Clinical Trial Update: A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection [Phase 3]

View source ↗

Summary

Phase III trial in adjuvant treatment of hepatitis virus–related hepatocellular carcinoma after surgical resection was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cancer

Drugs mentioned

• PI-88

Snippet

Sponsor: Cellxpert Biotechnology Corp. | Conditions: Cancer, Liver Cancer | Phase 3 | Status: TERMINATED | Results posted: 2020-12-30